common.study.topics.clinical

Identification of Biomarkers in Spinocerebellar Ataxia 3

common.study.values.description

Identification of Biomarkers in Spinocerebellar Ataxia 3

The purpose of this study is to examine the differences in cerebral spinal fluid (CSF) and blood of patients with spinocerebellar ataxias and healthy volunteers. The goal of this project is to identify new biomarkers that are useful for characterizing spinocerebellar ataxias and identify targets for treatment or prevention of this condition.

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

No pharmaceutical medication involved common.study.methods.has-drugs-no
Patients and healthy individuals accepted common.study.methods.is-healthy-no

Specimen Collection

No interventions take place as part of study participation- only specimen collection occurs for both cohorts.

participant.views.study.view.additional

participant.views.study.view.scientific-title

Identification of Biomarkers in Spinocerebellar Ataxia 3

common.study.values.clinical-trial-id

NCT03885167

participant.views.study.view.id

en5XPd